Tate & Lyle Interim Results Announcement 2009
1) Press release Please download the PDF for full press release.
2) 10.00am presentation to analyst and investors - webcast An audio webcast of the 2009 Interim Results Presentation will be available on this website from 10.00am GMT. A telephone dial-in facility is also provided for this event. Details are given below.
URL
Dial-in details UK: +44 (0) 203-003-2666 US: +1-866-966-5335 Replay Number (available for 1 week): UK: +44-20-8196-1998 US: +1-866-583-1035 Replay Access code: 691691#
3) 10.00am presentation to analyst and investors - presentation slides A pdf of the presentation will also be available on this website shortly after 10.00am GMT. This can be found in the Investor Relations area under 'Results', in the Press Office under 'Latest Presentations' or 'Press Pack'.
Tate Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.
Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
Tate Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2013, Tate Lyle sales totalled £3.3 billion. http://www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals, LLC
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
